1 May 2006 in Life Sciences
Monoamine oxidase (MAO), a mitochondrial flavine containing enzyme, exists in two isoenzymes, MAO-A and MAO-B. Platelets contain MAO-B subtype, proposed to be a biomarker for different personality characteristics and vulnerability for substance abuse. The most common polymorphism of MAO-B gene, a single base change (A or G) occurs in intron 13. It has been proposed to be a functional polymorphism, controlling the activity of MAO-B in platelets. The aim of the study was to determine the association between platelet MAO-B activity and MAO-B intron 13 polymorphism in 225 racially and ethnically uniform healthy Caucasian men of the Croatian origin. Our results showed that platelet MAO-B activity did not differ between subjects subdivided into those with <> or <>. This polymorphism of the MAO-B gene did not control the activity of the MAO-B in platelets. Platelet MAO-B activity was associated only with the smoking status, and it was significantly decreased in smokers when compared to nonsmokers. No significant association was found between MAO-B polymorphism and smoking status. In healthy individuals of the Croatian origin, the studied MAO-B polymorphism showed a lack of functional importance in regulating MAO-B activity in platelets. Since different populations may vary in the association between functional polymorphism and the MAO-B activity, and the genotype of transcription factor AP-2 beta was reported to be associated with altered platelet MAO-B activity, and with specific personality traits, further studies on different populations should be conducted to elucidate the molecular mechanism/s regulating platelet MAO-B activity.
5 May 2025 in Health Science Reports
Background and Aims: Many studies investigated the prevalence and severity of depression and anxiety among dentists. This systematic review aimed to determine: (i) the prevalence and severity of depression and anxiety symptoms, (ii) the prevalence rates of depression and anxiety before and during the COVID‐19 pandemic, and (iii) gender difference in prevalence of depression and anxiety among dentists. Methods: Eligible articles on depression and anxiety in dentists were systematically searched for in PubMed and Scopus databases from September 2023 to October 2023 according to the Preferred Reporting Items for Systematic Review and Meta‐Analysis protocol. We assessed the methodological quality of the studies using the Newcastle–Ottawa Quality Assessment checklist adapted for cross‐sectional studies. Statistical heterogeneity across the studies was evaluated using Cochran's Q test and I 2 statistic. The prevalence rates of depression and anxiety were calculated using the random‐effect model with the Restricted Maximum‐Likelihood estimator. Of 3762 searched articles, 33 articles were analyzed. Results: The prevalence rates of depression and anxiety symptoms among dentists were 42% and 44%, respectively. The prevalence rates of mild, moderate, and severe or extremely severe depression were 20%, 18%, and 8%, respectively. For mild, moderate, and severe or extremely severe anxiety, the respective prevalence rates were 21%, 18%, and 11%. We did not find evidence to suggest differences in depression or anxiety prevalence rates between the periods before and during COVID‐19. In comparison with men, women showed approximately 27% higher risk of experiencing depression and 24% higher risk of experiencing anxiety. Conclusion: Equally high levels of depression and anxiety in dentists were found both before and during the COVID‐19 pandemic, with a significant percentage of moderate to severe depression and anxiety. Female dentists reported a higher prevalence of depression and anxiety symptoms than their male colleagues.
6 June 2025 in Current Addiction Reports